NEW YORK, May 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis of the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets:
• Erythropoiesis Stimulating Agents (ESA)
• G-CSF & GM-CSF
• Thrombopoietin & Thrombopoiesis Stimulating Agents
• Coagulation Factors
• Human Growth Hormone (hGH)
• FSH etc
• Thrombolytics & Fibrinolytics
• Enzyme Replacement Therapies
Territories covered are the major pharmaceutical markets North America, Europe and Japan, as well as South Korea, India, China and other countries in Latin America, Africa and Australasia.
With more than US$ 50 bln in sal
Copyright©2012 PR Newswire.
All rights reserved